PRESCRIPTION PATTERN OF ANTIBIOTICS AND THEIR APPROPRIATENESS IN PATIENTS WITH CHRONIC KIDNEY DISEASE-AN OBSERVATIONAL STUDY IN A TERTIARY CARE TEACHING HOSPITAL IN SOUTH INDIA

PALLAVI CHALIVENDRA; UMAMAHESWARA RAO K.; J SUCHARITHA; VURIMI BHOPAL CHANDRA; ANJANI DEVI NELAVALA

doi:10.22159/ijcpr.2023v15i1.2077

Authors

PALLAVI CHALIVENDRA SVIMS, Sri Padmavathi Medical College for Women, Tirupathi
UMAMAHESWARA RAO K. SVIMS, Sri Padmavathi Medical College for Women, Tirupathi
J SUCHARITHA SVIMS, Sri Padmavathi Medical College for Women, Tirupathi
VURIMI BHOPAL CHANDRA Rama Medial College–Hospital and Research Center, Mandhana, Kanpur, UP
ANJANI DEVI NELAVALA Faculty of Nursing, Rama University, Mandhana, Kanpur, UP

DOI:

https://doi.org/10.22159/ijcpr.2023v15i1.2077

Keywords:

Chronic kidney disease, GFR, Antibiotics, Prescription

Abstract

Objective: The primary objective of the study was to assess the prescribing pattern of antimicrobial agents in patients with chronic kidney disease. The secondary objectives of this study are to assess antibiotic appropriateness and dose optimization in patients with chronic kidney disease in relation to their comorbidities.

Methods: A retrospective study was conducted, and medical records of all patients with CKD who were admitted in the nephrology department of Sri Venkateswara Institute of Medical Sciences, Tirupati, during Jan 2018-Dec 2018 were reviewed for antibiotic prescriptions. A total of 200 medical records were selected and assessed for antimicrobial prescriptions. A p-value <0.05 was considered significant throughout the statistical analysis.

Results: Analysis showed that overall 163 drugs were prescribed to CKD patients, of which nearly 96 (58.9%) required dosage adjustment. Of those 163 drugs, the majority N= 25 (26%), were unadjusted, and the remaining N = 71 (74%) were properly adjusted. The length of hospitalization of CKD patients was below 7 was 13.5%, above 7 was 86.5%. Mean and SD was 10.27±7.18 d, (Range: 1–35 d). The Chi-square analysis confirmed that out of the seven studied variables, two i.e. Length of stay days; p<0.001.

Conclusion: It is concluded that the occurrence of medication dosing errors was moderate in hospitalized chronic kidney disease patients in our study. Nearly 20% of patients who had prolonged stays were prescribed antibiotics for a prolonged period. The predictors of medication dosing errors in CKD patients were the severe-to-end stages of chronic kidney disease, the number of prescribed antibiotics, and the length of hospitalization.

Downloads

Download data is not yet available.

References

Bukar AA, Sulaiman MM, Ladu AI, Abba AM, Ahmed MK, Marama GT. Chronic kidney disease amongst sickle cell anaemia patients at the University of Maiduguri Teaching Hospital, Northeastern Nigeria: a study of prevalence and risk factors. Mediterr J Hematol Infect Dis. 2019;11(1):e2019010. doi: 10.4084/MJHID.2019.010, PMID 30671216.

Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022 Apr 1;12(1):7-11. doi: 10.1016/j.kisu.2021.11.003, PMID 35529086.

GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709-33. doi: 10.1016/S0140-6736(20)30045-3, PMID 32061315.

Kumar V, Yadav AK, Sethi J, Ghosh A, Sahay M, Prasad N. The Indian chronic kidney disease (ICKD) study: baseline characteristics. Clin Kidney J. 2022 Jan;15(1):60-9. doi: 10.1093/ckj/sfab149, PMID 35035937.

Scheen AJ. Pharmacokinetics, pharmacodynamics and clinical use of SGLT2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease. Clin Pharmacokinet. 2015 Jul;54(7):691-708. doi: 10.1007/s40262-015-0264-4, PMID 25805666.

Ozoux ML, Briand V, Pelat M, Barbe F, Schaeffer P, Beauverger P. Potential therapeutic value of urotensin II receptor antagonist in chronic kidney disease and associated comorbidities. J Pharmacol Exp Ther. 2020 Jul 1;374(1):24-37. doi: 10.1124/jpet.120.265496, PMID 32332113.

Waikar SS, Srivastava A, Palsson R, Shafi T, Hsu CY, Sharma K. Association of urinary oxalate excretion with the risk of chronic kidney disease progression. JAMA Intern Med. 2019 Apr 1;179(4):542-51. doi: 10.1001/jamainternmed.2018.7980, PMID 30830167.

Saleem A, Masood I. Pattern and predictors of medication dosing errors in chronic kidney disease patients in Pakistan: a single center retrospective analysis. Plos One. 2016 Jul 1;11(7):e0158677. doi: 10.1371/journal.pone.0158677, PMID 27367594.

Hui K, Nalder M, Buising K, Pefanis A, Ooi KY, Pedagogos E. Patterns of use and appropriateness of antibiotics prescribed to patients receiving haemodialysis: an observational study. BMC Nephrol. 2017 Dec;18(1):156. doi: 10.1186/s12882-017-0575-9, PMID 28499421.

Saleem A, Masood I, Khan TM, Nawaz M. Potential drug-drug interactions in renal impairment patients in Pakistan. Value Health. 2016 May 1;19(3):A12. doi: 10.1016/j.jval.2016.03.262.

D’Agata EMC, Lindberg CC, Lindberg CM, Downham G, Esposito B, Shemin D. The positive effects of an antimicrobial stewardship program targeting outpatient hemodialysis facilities. Infect Control Hosp Epidemiol. 2018 Dec;39(12):1400-5. doi: 10.1017/ice.2018.237, PMID 30253815.